CERo Therapeutics Inc.
(CERO)
undefined
undefined%
At close: undefined
0.06
0.52%
After-hours Jan 03, 2025, 05:58 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 |
| Revenue | n/a | n/a | n/a |
| Cost of Revenue | n/a | n/a | n/a |
| Gross Profit | n/a | n/a | n/a |
| Operating Income | -2.93M | -2.91M | -332.03K |
| Interest Income | 491.57K | 142.12K | 986.71K |
| Pretax Income | -2.44M | -68.58K | -332.42K |
| Net Income | -2.54K | -667.74K | -315.55K |
| Selling & General & Admin | 2.89M | 2.84M | 251.71K |
| Research & Development | n/a | 9.85M | 9.14M |
| Other Expenses | 40.05K | -64.05K | -80.32K |
| Operating Expenses | 2.93M | 2.91M | 332.03K |
| Interest Expense | n/a | n/a | n/a |
| Selling & Marketing Expenses | 2.89M | 715.76K | -2.23M |
| Cost & Expenses | 2.93M | 2.91M | 332.03K |
| Income Tax | 94.82K | 599.16K | -16.87K |
| Shares Outstanding (Basic) | 6.53M | 6.77M | 22.98M |
| Shares Outstanding (Diluted) | 6.53M | 6.77M | 22.98M |
| EPS (Basic) | -0.39 | -0.1 | -0.01 |
| EPS (Diluted) | -0.39 | -0.1 | -0.01 |
| EBITDA | -2.44M | -68.58K | -332.03K |
| Depreciation & Amortization | 2.93K | 1.07M | 735.47K |